|
|
|
|
Intellectual Property
Patents, trade secrets and other intellectual property rights protect Novilase. Novian Health owns and controls all of the rights in the intellectual property. The patents include nine issued U.S. patents, shown below, and additional U.S. patent applications. In addition, appropriate foreign filings have been made.
|
PAT. NO.
|
TITLE
|
| 7,171,253 |
Apparatus and method for delivering ablative laser energy and determining the volume of tumor mass destroyed |
| 7,041,109 |
Apparatus and method for interstitial laser therapy of small breast cancers and adjunctive therapy |
| 6,865,412 |
Apparatus and method for delivering ablative laser energy and determining the volume of tumor mass destroyed |
| 6,701,175 |
Apparatus and method for delivering ablative laser energy and determining the volume of tumor mass destroyed |
| 6,603,988 |
Apparatus and method for delivering ablative laser energy and determining the volume of tumor mass destroyed |
| 5,853,366 |
Marker element for interstitial treatment and localizing device and method using same |
| 5,569,240 |
Apparatus for interstitial laser therapy |
| 5,222,953 |
Apparatus for interstitial laser therapy having an improved temperature sensor for tissue being treated |
| 5,169,396 |
Method for interstitial laser therapy |
Novian Health continues to improve the ILT Device and procedures, filing patents on the improvements and ancillary products. It is intended that the intellectual property rights will remain 100% owned by Novian Health.
|
 |
